Effect of Belimumab on Antibody Titers in Primary APS Patients

Clinical trial NCT06747312 · RECRUITING

Trial details

NCT number: NCT06747312
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Antiphospholipid Syndrome (APS)

Start date: 2024-04-01
Primary completion: 2026-05-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.